Published in Eur J Clin Microbiol on June 01, 1986
Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev (2004) 2.95
Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group. J Clin Microbiol (1999) 1.59
Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J (1990) 1.54
In vitro model for the nuclear transport of the hepadnavirus genome. J Virol (1997) 1.38
Genotyping by multiplex polymerase chain reaction for detection of endemic hepatitis B virus transmission. J Clin Microbiol (1993) 1.12
Quantitative assay of PCR-amplified hepatitis B virus DNA using a peroxidase-labelled DNA probe and enhanced chemiluminescence. J Clin Microbiol (1996) 1.07
Rapid chemiluminescent nucleic acid assays for detection of TEM-1 beta-lactamase-mediated penicillin resistance in Neisseria gonorrhoeae and other bacteria. J Clin Microbiol (1988) 1.06
Evaluation of SHARP signal system for enzymatic detection of amplified hepatitis B virus DNA. J Clin Microbiol (1995) 0.94
Evaluation of the commercially available HepProbe kit for detection of hepatitis B virus DNA in serum. J Clin Microbiol (1990) 0.84
Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus. Clin Exp Immunol (1991) 0.83
The effectiveness of lamivudine treatment in cirrhotic patients with HBV precore mutations: a prospective, open-label study. Dig Dis Sci (2006) 0.77
Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol (1984) 6.90
Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand. Cell (1980) 5.21
Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. J Virol (1986) 3.63
Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol (1992) 3.59
Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells. Eur J Immunol (1975) 3.37
Structural relationships between minor and major proteins of hepatitis B surface antigen. J Virol (1983) 3.09
Selective detection of IgM-antibody against core antigen of the hepatitis B virus by a modified enzyme immune assay. J Med Virol (1979) 2.68
Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol (1999) 2.52
Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J (1994) 2.35
Structural relationships between the surface antigens of ground squirrel hepatitis virus and human hepatitis B virus. J Virol (1980) 2.20
Reliability of methods for hepatitis B virus DNA detection. J Clin Microbiol (1995) 2.16
Formation of transmembraneous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein. Virology (1988) 2.11
[HIV-p24 antigen test in blood donors: yes or no?]. Med Klin (Munich) (1994) 2.02
Precore sequence of hepatitis B virus inducing e antigen and membrane association of the viral core protein. Virology (1986) 2.01
Specificity and localization of the hepatitis B virus-associated protein kinase. J Virol (1982) 2.00
Acute hepatitis A in haemophiliacs. Lancet (1992) 1.96
Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex. J Cell Biol (1999) 1.92
Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection. Transfusion (2000) 1.85
Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus. J Virol (1994) 1.78
Variable protein composition of hepatitis B surface antigen from different donors. Virology (1982) 1.77
Mapping a region of the large envelope protein required for hepatitis B virion maturation. J Virol (1994) 1.73
Subjective effects of double gloves on surgical performance. Ann R Coll Surg Engl (1996) 1.71
Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc Natl Acad Sci U S A (1994) 1.66
Standardized detection of hepatitis B surface antigen: determination of its serum concentration in weight units per volume. Dev Biol Stand (1975) 1.63
Sequence of the Candida albicans gene encoding the secretory aspartate proteinase. J Med Vet Mycol (1991) 1.61
Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group. J Clin Microbiol (1999) 1.59
Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles. Virology (1989) 1.59
Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J (1990) 1.54
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol (2003) 1.53
Experimental non-A, non-B hepatitis: four types of cytoplasmic alteration in hepatocytes of infected chimpanzees. Virchows Arch B Cell Pathol Incl Mol Pathol (1980) 1.43
International collaborative study on the second EUROHEP HCV-RNA reference panel. J Virol Methods (1996) 1.41
Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA. Am Heart J (1999) 1.41
Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections. J Clin Microbiol (1986) 1.41
In vitro model for the nuclear transport of the hepadnavirus genome. J Virol (1997) 1.38
Nondifferentiation between Lyme disease spirochetes from vector ticks and human cerebrospinal fluid. J Infect Dis (1995) 1.33
Hepatitis B virus core gene mutations which block nucleocapsid envelopment. J Virol (2000) 1.31
Nucleotide sequence of the ospAB operon of a Borrelia burgdorferi strain expressing OspA but not OspB. Infect Immun (1992) 1.29
Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer (1994) 1.27
Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet (2000) 1.26
Identification of a new hepatitis B virus (HBV) genotype from Brazil that expresses HBV surface antigen subtype adw4. J Gen Virol (1993) 1.26
[Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline]. Z Gastroenterol (2011) 1.24
Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus. Med Microbiol Immunol (2000) 1.22
Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. Hepatology (2000) 1.22
Identification of a binding site in the hepatitis B virus RNA pregenome for the viral Pol gene product. Virology (1991) 1.21
Different pattern of elution of poliovirus strains from DEAE-cellulose and aluminium hydroxide gel. Arch Gesamte Virusforsch (1965) 1.21
Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line. J Virol (1996) 1.20
Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr Suppl (1993) 1.13
Genotyping by multiplex polymerase chain reaction for detection of endemic hepatitis B virus transmission. J Clin Microbiol (1993) 1.12
Immunogenicity of the gene S and Pre-S domains in hepatitis B virions and HBsAg filaments. Intervirology (1987) 1.11
Characterization of pre-s gene products in hepatitis B surface antigen. Dev Biol Stand (1983) 1.08
Quantitative assay of PCR-amplified hepatitis B virus DNA using a peroxidase-labelled DNA probe and enhanced chemiluminescence. J Clin Microbiol (1996) 1.07
Topology and immunoreactivity of capsid proteins in hepatitis A virus. Med Microbiol Immunol (1983) 1.06
In vitro tumorigenicity of hepatitis B virus DNA and HBx protein. J Hepatol (1991) 1.06
Etiology of the acrodermatitis chronica atrophicans lesion in Lyme disease. J Infect Dis (1996) 1.05
Liquid-phase hybridization and capture of hepatitis B virus DNA with magnetic beads and fluorescence detection of PCR product. J Virol Methods (1994) 1.05
Letter: Flower vases and pathogens. Lancet (1974) 1.04
Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J Virol (1998) 1.04
Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J Virol (1997) 1.03
The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface. J Gen Virol (1992) 1.03
Characterization of the endogenous protein kinase activity of the hepatitis B virus. Arch Virol Suppl (1993) 1.03
Hepatic expression patterns of the large and middle hepatitis B virus surface proteins in viremic and nonviremic chronic hepatitis B. Gastroenterology (1990) 1.01
Genomic alterations of the c-myc protooncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinomas. J Cancer Res Clin Oncol (1991) 0.99
Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts. Oncogene (2000) 0.99
Extensive mutagenesis of the hepatitis B virus core gene and mapping of mutations that allow capsid formation. J Virol (1999) 0.98
Characterization of Borrelia burgdorferi strains in Lyme arthritis. Scand J Infect Dis (1998) 0.98
Tissue donation and virus safety: more nucleic acid amplification testing is needed. Transpl Infect Dis (2010) 0.97
Molecular approaches to validate disinfectants against human hepatitis B virus. Med Microbiol Immunol (2002) 0.97
HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Invest Dermatol (1999) 0.96
Analysis of the pre-S2 N- and O-linked glycans of the M surface protein from human hepatitis B virus. J Biol Chem (1999) 0.96
Unrestraining genetic processes with a protein-DNA hinge. Mol Cell (1998) 0.96
Proteins of hepatitis delta virus. Prog Clin Biol Res (1987) 0.95
Identification of an immunoreactive non-proteinaleous component in Borrelia burgdorferi. Med Microbiol Immunol (1991) 0.95
Antibodies to human papillomavirus type-16 in human sera as revealed by the use of prokaryotically expressed viral gene products. Virology (1991) 0.95
Schistosoma mansoni: cercarial penetration and schistosomule collection in an in vitro system. Exp Parasitol (1969) 0.94
Diagnosis of acute and inapparent hepatitis B virus infections by measurement of IgM antibody to hepatitis B core antigen. J Infect Dis (1980) 0.94
Unsatisfactory specificities and sensitivities of six enzyme immunoassays for antibodies to hepatitis B core antigen. J Clin Microbiol (1989) 0.94
Safety and potency aspects in the preparation of an experimental HBsAg vaccine. Dev Biol Stand (1983) 0.93
Outbreak of hepatitis B in a nursing home associated with capillary blood sampling. Epidemiol Infect (2006) 0.92
No homology detectable between Marek's disease virus (MDV) DNA and herpesvirus of the turkey (HVT) DNA. Med Microbiol Immunol (1979) 0.92
Detection of a hepatitis B virus variant with a truncated X gene and enhancer II. Arch Virol (1992) 0.92
Labile evolution of display traits in bowerbirds indicates reduced effects of phylogenetic constraint. Proc Biol Sci (1997) 0.92
Peripheral facial palsy in childhood--Lyme borreliosis to be suspected unless proven otherwise. Acta Paediatr Scand (1990) 0.91
Occurrence of antibodies to L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controls. Int J Cancer (1991) 0.91
Interaction between hepatitis B surface proteins and monomeric human serum albumin. Hepatology (1990) 0.91
Expression pattern of the hepatitis B virus genome in transfected mouse fibroblasts. Virology (1990) 0.90
Increase in immunoglobulin M antibodies against gut bacteria during acute hepatitis A. Infect Immun (1983) 0.90
Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype. J Gen Virol (2000) 0.90
Structure and glycosylation patterns of surface proteins from woodchuck hepatitis virus. J Virol (1998) 0.89
Hemifusion activity of a chimeric influenza virus hemagglutinin with a putative fusion peptide from hepatitis B virus. Virus Res (2000) 0.89